The day your 510(k) clears is one of the most significant milestones in a medical device company's life. After months -- sometimes years -- of testing, documentation, and FDA review, you finally have the green light to bring your device to market. And then the real challenge begins.

Because here is the uncomfortable truth: 510(k) clearance does not sell devices. It gives you permission to sell them. The gap between regulatory clearance and commercial success is enormous, and it is where most medical device companies struggle the most. They have spent so much time, money, and energy on the regulatory process that marketing feels like an afterthought -- something to figure out after clearance, not before.

I have spent 18 years helping medical device companies navigate this exact transition. From radiation protection products to surgical visualization systems to orthopedic implants, I have seen the pattern repeat: brilliant engineers build extraordinary devices, navigate the FDA process successfully, and then have no idea how to tell the market about it in a way that complies with regulations and actually drives adoption.

This guide is about building a marketing strategy that leverages your 510(k) clearance as a commercial asset -- while staying firmly within the regulatory guardrails that govern how you can promote your device.

Understanding What 510(k) Clearance Means for Marketing

Before we talk about strategy, we need to establish what 510(k) clearance actually gives you from a marketing perspective. This is where I see the most confusion -- and the most risk.

A 510(k) clearance means the FDA has determined that your device is substantially equivalent to a legally marketed predicate device. That is it. It does not mean the FDA has endorsed your device. It does not mean the FDA has confirmed it is safe and effective in absolute terms. It means your device is substantially equivalent to something already on the market.

This distinction matters enormously for your marketing:

I worked with a radiation protection company that had just received 510(k) clearance for a new line of protective garments. Their engineering team was eager to promote the product's performance advantages over competitors, citing internal testing data that went well beyond what was included in the 510(k) submission. We had to carefully distinguish between claims supported by the cleared labeling and claims that required additional evidence or regulatory review before they could be used in marketing. That distinction saved them from a potential compliance issue that could have undermined their entire launch.

Understanding these boundaries is not optional. It is the foundation of every marketing decision you will make. For more detail on navigating FDA marketing requirements, see our guide on FDA marketing compliance.

Why You Should Start Marketing Before Clearance

The biggest strategic mistake I see is waiting until after clearance to start marketing. By the time you receive your clearance letter, your marketing engine should already be warmed up and ready to deploy.

Here is what you can do before clearance:

Disease Awareness and Education

You cannot promote a specific device before clearance, but you can educate the market about the clinical problem your device solves. Create content about the condition, the limitations of current approaches, and the unmet needs in the field. This positions you as a thought leader and primes the market to be receptive when your device does clear. The educational content you create during this phase also serves as evergreen marketing material that continues to drive organic traffic and engagement long after launch.

Brand Building

Develop your company brand, build your website infrastructure, establish your social media presence, and create relationships with medical editors and journalists. None of this is product promotion -- it is company building, and it is perfectly permissible. A strong company brand creates a halo effect that benefits every product you eventually bring to market.

Sales Infrastructure

Hire and train your sales team. Develop your sales process. Build your CRM infrastructure. Identify target accounts and begin building relationships with key stakeholders at priority hospitals and health systems. Establish distributor relationships and negotiate contract terms. All of this takes time, and none of it requires clearance.

KOL Relationships

Engage key opinion leaders through your clinical trial relationships. These clinicians already know your device. Build the advisory and advocacy relationships now so they are ready to support your launch the moment clearance comes through. KOLs who are involved early feel ownership over the device and become its most passionate and credible advocates.

Marketing Collateral Development

Prepare your marketing materials -- brochures, website content, sales presentations, trade show graphics -- in advance. Have them ready for final regulatory review as soon as clearance is received. Do not start writing your first brochure after the clearance letter arrives. The companies that launch fastest after clearance are the ones that prepared everything in advance and just needed the final MLR sign-off.

Pre-Clearance Marketing Rule: Everything you do before clearance must be non-promotional regarding your specific device. You can talk about the disease. You can talk about your company. You can talk about unmet clinical needs. You cannot talk about your product's features, benefits, or clinical performance. The line between education and promotion is real, and crossing it before clearance can create serious regulatory problems that jeopardize your entire market entry.

Building Your Post-Clearance Messaging Framework

The moment your clearance comes through, you need to move fast. The first 90 days after clearance set the tone for your entire market entry. Having a messaging framework ready to deploy is essential.

Your post-clearance messaging framework should include:

Primary Value Proposition

One clear, compelling statement about why this device matters. It should be clinically grounded, supported by your cleared labeling, and differentiated from existing alternatives. Do not try to say everything -- say the one thing that matters most. The most powerful value propositions in medtech are the ones that address a specific, widely recognized clinical frustration with a specific, evidence-backed solution.

Cleared Claims Library

Create a master document of every claim your team is authorized to make about the device. Each claim should reference the supporting evidence and the regulatory basis for making it. This document is the single source of truth for every marketer, salesperson, and agency you work with. Without it, claims drift -- sales reps improvise language, marketers exaggerate benefits, and compliance issues accumulate silently until someone gets a warning letter.

Stakeholder-Specific Messaging

Develop separate messaging tracks for each stakeholder in the buying process:

Competitive Positioning

Develop clear, defensible statements about how your device compares to the competition. Remember: comparative claims require substantiation. Do not make claims you cannot support with data. Focus on your genuine points of differentiation -- the areas where your device demonstrably outperforms alternatives -- rather than trying to claim superiority across every dimension.

Content Strategy After Clearance

Content is the engine of modern medical device marketing. After clearance, you need a content strategy that builds clinical credibility, supports the sales process, and drives organic discovery -- all within regulatory boundaries.

Here is how I structure content strategy for newly cleared devices:

Clinical Content

Educational Content

Sales Enablement Content

All content must go through your MLR (medical-legal-regulatory) review process before distribution. Build this into your content calendar with adequate review time -- typically two to four weeks per piece, depending on complexity. Rushing MLR review is one of the fastest ways to introduce compliance risk into your marketing program.

Digital Marketing Strategy for Cleared Devices

Digital marketing is where most medical device companies are weakest. They invest heavily in trade shows and sales reps but underinvest in the digital channels where their customers are increasingly doing research.

Website Optimization

Your website is your most important marketing asset after clearance. It needs to accomplish several things simultaneously:

Every page on your website that mentions your device should be reviewed through your MLR process. This includes landing pages, blog posts, and even meta descriptions that appear in search results.

Search Engine Optimization

Surgeons and hospital administrators search Google for solutions to clinical problems. If your website does not appear in those search results, you are invisible to a huge portion of your potential market. SEO for medical devices requires targeting clinical keywords, building authoritative content, and earning backlinks from reputable medical sources. It also requires patience -- SEO results compound over time, and the content you publish in the first six months after clearance will continue generating leads for years.

Paid Search and Social

Targeted advertising on Google and LinkedIn can accelerate awareness for newly cleared devices. The key is precise targeting -- by specialty, by job title, by geography -- so you reach the right people without wasting budget on irrelevant impressions. LinkedIn is particularly effective for reaching hospital administrators and procurement decision-makers who are difficult to reach through other channels.

Email Marketing

Build an email list of interested clinicians and administrators from the start. Use email to nurture leads with educational content, clinical updates, and event invitations. Segment your list by stakeholder type and stage in the buying process so you deliver relevant content to each recipient rather than blasting your entire list with the same message.

Digital Compliance Note: Every digital marketing channel is subject to the same FDA promotional regulations as traditional marketing. Your Google ads, LinkedIn posts, email campaigns, and website content all need MLR review. Do not assume that digital channels are somehow exempt from regulatory oversight. They are not, and the FDA has issued warning letters for violations in digital channels including social media posts, website claims, and paid search advertising.

Trade Show Strategy After Clearance

Medical conferences are a critical channel for newly cleared devices. They offer concentrated access to your target audience, opportunities for clinical presentations, and the chance to generate buzz in a way that digital channels cannot replicate.

Your post-clearance trade show strategy should include:

For a comprehensive approach to conference marketing, read our medical device product launch guide.

Sales Enablement After Clearance

Your sales team is only as effective as the tools and training you give them. After clearance, sales enablement becomes a critical marketing function that directly affects revenue velocity.

Essential sales enablement components include:

Navigating the Cleared vs. Approved Distinction

This point is important enough to warrant its own section. The difference between "cleared" and "approved" is not semantic -- it is regulatory and legal.

Devices that go through the 510(k) pathway are cleared. This means the FDA has found them to be substantially equivalent to a predicate device. The 510(k) pathway is for devices that are not entirely new -- they are similar to something already on the market.

Devices that go through the Premarket Approval (PMA) pathway are approved. PMA is for higher-risk devices (typically Class III) and requires clinical trial data demonstrating safety and effectiveness.

Why does this matter for marketing?

Train every member of your team -- marketing, sales, customer service, executive leadership -- to use the correct terminology. Review every piece of content, every press release, every social media post for this distinction. It seems small, but it matters enormously. Our regulatory marketing services can help ensure your messaging stays compliant across every channel.

Reimbursement and Market Access Marketing

A device that is not reimbursed is a device that most hospitals will not adopt. Reimbursement strategy is not just a market access issue -- it is a marketing issue that directly affects your commercial viability.

Your marketing strategy should address reimbursement in several ways:

Building Long-Term Brand Equity After Clearance

The first year after clearance sets the trajectory for your brand in the market. The decisions you make about how to present your device, how to engage with clinicians, and how to build your evidence base will compound over time.

Long-term brand building in medtech requires:

Common Post-Clearance Marketing Mistakes

I have seen these mistakes enough times that they deserve explicit mention:

The Path Forward

510(k) clearance is the starting line, not the finish line. The companies that build the strongest market positions after clearance are the ones that invest in marketing strategy with the same rigor they applied to their regulatory submissions.

Start before clearance. Build your messaging framework on a foundation of cleared claims. Create content that builds clinical credibility. Deploy digital marketing alongside traditional channels. Enable your sales team with data-backed tools. And measure everything so you can continuously improve.

The medical device market rewards companies that combine clinical innovation with marketing sophistication. Your device earned its clearance. Now make sure the market knows about it -- the right way.